BrightGene Bio-Medical Technology Co.
Latest round
- Series A
Last raised
- Aug 2014
Total raised
- Undisclosed
Investors
- 2
About BrightGene Bio-Medical Technology Co.
, Ltd. operates as an API and preparation developer that mainly provides original new drugs., Ltd. was listed on the Shanghai Stock Exchange. The company mainly provides API and preparation drugs. The product line covers multiple therapeutic areas such as antiviral, antifungal, immunosuppressive, anti-tumor, cardiovascular and cerebrovascular, respiratory, and iron supplements. Products include BGM0504 injection, entecavir, pimecrolimus, and micafungin sodium for injection. The company generates revenue by providing API and preparation drugs such as BGM0504 injection and entecavir.
Who invested in BrightGene Bio-Medical Technology Co.
2 investors across 1 round
See all investors in BrightGene Bio-Medical Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 22, 2014
Amount
Undisclosed
Investors
Questions about BrightGene Bio-Medical Technology Co.
Who invested in BrightGene Bio-Medical Technology Co.?
BrightGene Bio-Medical Technology Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BrightGene Bio-Medical Technology Co. raised?
BrightGene Bio-Medical Technology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BrightGene Bio-Medical Technology Co. last raise money?
BrightGene Bio-Medical Technology Co.'s most recent round on record is a Series A, in Aug 2014.
What does BrightGene Bio-Medical Technology Co. do?
BrightGene Bio-Medical Technology Co. is a pharmaceuticals company.
Where is BrightGene Bio-Medical Technology Co. headquartered?
BrightGene Bio-Medical Technology Co. is headquartered in Suzhou, China.
Which VCs invest in companies like BrightGene Bio-Medical Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at BrightGene Bio-Medical Technology Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like BrightGene Bio-Medical Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.